top of page
Team
Our Mission of Discovery
At Halia Therapeutics we are discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. We do this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses.
Team
Alexis Mollard, PhD
Sr. Director Medicinal Chemistry
Devan Bursey
Scientist
Andrea "Andi" Groen
Director of Operations
Margit Janat-Amsbury, MD, PhD
Chief Medical Officer
Anya Neidig, MSN, RN
Director of Clinical Operations
Taylor Avei
Business Development Representative
Partners
bottom of page